From the Mediterranean diet to probiotics, scientists reveal how rebuilding the gut microbiome can help protect brain function and highlight why timing is critical to slowing cognitive decline.
Research: Association between gut microbiota and cognitive decline: a systematic review of the literature. Image credit: Toa55/Shutterstock.com
The gut-brain axis is gaining importance as a factor regulating the health of brain function. recent papers nutrition research synthesized evidence from Literature shows multiple approaches to manipulating the gut microbiome share common biological pathways to improve cognitive performance in adults aged 45 and older Have cognitive impairment or are at risk of dementia.
Aging gut microbiota is associated with dementia risk
Multiple neurodegenerative diseases such as Alzheimer’s disease (AD) are mediated In part, this is due to changes in the gut-brain axis caused by age-related changes in the gut microbiota. Dementia is progressive and irreversible, causing a decline in neurological function and a shortened lifespan.
This is in contrast to the early stages of mild cognitive impairment (MCI), a cognitive impairment in which functional impairment is detectable but usually does not affect daily life.
Gut-brain mechanisms underlying cognitive decline
The gut-brain axis is a two-way communication system between the central nervous system and the gut. This includes signaling through neural, hormonal, and immune mediators. Recent studies have established its important role in regulating neurodevelopment, mood, and cognition.
However, age- and diet-related changes in the gut microbiota can induce dysbiosis, which is thought to contribute to the development of neurodegeneration.
In intestinal dysbiosis, the intestinal epithelial barrier is compromised. This allows molecular patterns associated with bacteria and microorganisms to enter the bloodstream. The resulting systemic endotoxemia can cause chronic low-grade inflammation. Abnormalities in the gut microbiota also cause abnormalities in immune cells, leading to a systemic pro-inflammatory state.
Systemic inflammation can weaken the blood-brain barrier (BBB) and expose the brain to pro-inflammatory triggers and mediators. The resulting neuroinflammation is associated with the accumulation of abnormal proteins such as amyloid-beta and tau, which are hallmarks of Alzheimer’s disease. Nerve synapses are damaged and their function is impaired. The end result is cognitive decline as part of aging or Alzheimer’s disease.
The microbiome, immune system, and brain are in a continuous dialogue, and a disturbance in one component can reverberate throughout the system, creating a vicious cycle that promotes cognitive decline.
Microbiome research evolves from observation to intervention
The researchers outlined the progress of such research. Following the earliest purely descriptive studies of gut microbial responses, advances in DNA and RNA sequencing and metabolomics led to detailed characterization of the microbiome. This was followed by current intervention studies focusing on more powerful mechanisms.
Integrating evidence on dysbiosis and cognition
The authors aimed to synthesize evidence from studies targeting different microbiota-targeted interventions individually. They reviewed the literature on cognitive changes in adults aged 45 and older with cognitive impairment or at risk for dementia who participated in experimental manipulation of their gut microbiota.
Interventions include probiotics, prebiotics, methyl donor supplementation, omega-3 fatty acid intake, synbiotics, fecal microbiota transplantation (FMT), and dietary treatments such as the Mediterranean or keto diets. Patients were evaluated for inflammatory and metabolic changes, as well as changes in fecal microbiota.
Changes in the microbiome are associated with improved cognitive function
This review included 15 studies covering a variety of demographic characteristics. Study samples ranged from 5 to over 1,200 participants. In total, there were 4,275 participants.
Only two studies, both RCTs, achieved a score of 100% based on the quality score criteria, and one additional quasi-experimental study also achieved a score of 100%. It is almost impossible to blind a dietary intervention, but this introduces bias. Still, most studies maintained a quality score of 76.9% or higher.
The results of this study show that memory, executive function, and overall cognitive function are improved in association with multiple dietary approaches to modulate the gut microbiome. The improvement was most pronounced in MCI patients.
In patients with advanced Alzheimer’s disease, the effect of modulating the gut microbiota was limited.
Dietary intervention and gut microbiota
The benefits of these approaches to cognition have been correlated with increased gut microbial diversity, which led to increased production of short chain fatty acids (SCFA). Higher SCFA levels are associated with lower levels of neuroinflammatory markers.
Diets such as the Mediterranean diet and the keto diet increase the amount of SCFA-producing bacteria in the gut. SCFAs are thought to be associated with reducing oxidative stress and improving mitochondrial function. This may facilitate the removal or reduce the accumulation of abnormal proteins associated with Alzheimer’s disease, contributing to improved cognitive outcomes.
Bile acids from the liver are modified by beneficial gut bacteria. Like SCFAs, they help regulate lipid metabolism in the brain and throughout the body. This is essential for neuron health and function.
Keto diet reportedly improved cognitive performanceassociated with an increase in the relative abundance of species such as . Akkermansia muciniphila, which one Strengthens the intestinal barrier and promotes anti-inflammatory effects. The Mediterranean diet also promotes anti-inflammatory and antioxidant effects through monounsaturated fatty acids.
Probiotics directly introduce bacterial strains that can produce inhibitory neurotransmitters such as GABA. This may help prevent or reduce damage caused by excess excitatory neurotransmitters associated with MCI and AD. Probiotics may also promote the colonization of microorganisms that produce neuroprotective nutrients, facilitate the transfer of nutrients between the host and microbiota, and reduce inflammation.
Fecal microbiota transplantation (FMT) produces rapid and stable changes in the gut microbiome and was associated with increased bacterial diversity and altered expression of genes involved in lipid metabolism, as well as improved cognitive scores, in a small preliminary study. However, these findings are based on very small uncontrolled studies, and standardized testing protocols and long-term data are still needed to confirm reproducibility and clinical relevance.
The APOE ε4 allele is associated with a higher risk of AD. Based on recent evidence, the authors now suggest that this is partially mediated by dysbiosis of the gut microbiota resulting from APOE4-associated disruption of central nervous system lipid metabolism. This promotes neuroinflammation and BBB permeability.
At the intestinal level, changes in lipid pathways and bile acid modifications are reflected in dysbiosis of the gut microbiota, which is perpetuated by associated systemic inflammation and reduced mucosal immunity. Therefore, dietary approaches to microbiome regulation may reduce risk in specific ways depending on genetic makeup. However, this remains a hypothesis and requires further validation in large, well-designed clinical studies.
Research limitations
The authors note several limitations of this review. Meta-analysis was not possible due to substantial heterogeneity. Therefore, a narrative review was conducted. Only English-language publications were included in the search, resulting in language bias, and variation in study characteristics precluded direct comparison of results.
For these reasons, the results should be interpreted with caution. Future studies should use larger scale and robust methods to enable definitive analysis of the effects of nutritional interventions on gut microbiome-mediated cognitive function.
Large-scale trials are needed to validate microbiome interventions
This study integrates multiple approaches to gut microbiota regulation and evaluates the results, linking them to fundamental pathways linking systemic and neurometabolism, immune regulation, and inflammation. We also emphasize the importance of early intervention, as such approaches have limited success rates in advanced AD compared to MCI and early AD. Finally, we suggest mechanistic pathways related to specific aspects of cognition.
These findings suggest that these different diet-based approaches hold promise as non-pharmacological tools to enhance cognitive health in combination with pharmacotherapy and lifestyle interventions. Despite their biological plausibility, further large-scale RCTs with long-term follow-up are needed to validate them as therapeutic targets for dementia prevention.
Click here to download your PDF copy.
